Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cells
Article in Expert Review of Vaccines (September 2024)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in Expert Review of Vaccines (September 2024)
Article in International Journal of Health Policy and Management (August 2024)
Article in Biomolecules (August 2024)